Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Linotte

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Clinical Psychopharmacology|June 23, 2011
Switching antidepressant class does not improve response or remission in treatment-resistant depressionDaniel Souery, Alessandro Serretti, Raffaella Calati, et al.
International Clinical Psychopharmacology|July 14, 2009
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patientsAlessandro Serretti, Raffaella Calati, Isabelle Massat, et al.
International Clinical Psychopharmacology|May 11, 2010
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorderMagali Noro, Irina Antonijevic, Carlos Forray, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 20, 2012
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorderPeter Höfer, Alexandra Schosser, Raffaella Calati, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 9, 2010
Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypesNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
International Clinical Psychopharmacology|December 29, 2010
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorderNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
Journal of Affective Disorders|July 21, 2010
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depressionAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2003
Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European studyPierre Oswald, Daniel Souery, Isabelle Massat, et al.
Psychiatry Research|December 21, 2010
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depressionAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Neuroscience Letters|May 24, 2011
COMT and age at onset in mood disorders: a replication and extension studyIsabelle Massat, Neslihan Aygun Kocabas, Concetta Crisafulli, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Clinical Psychopharmacology|June 23, 2011
Switching antidepressant class does not improve response or remission in treatment-resistant depressionDaniel Souery, Alessandro Serretti, Raffaella Calati, et al.
International Clinical Psychopharmacology|July 14, 2009
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patientsAlessandro Serretti, Raffaella Calati, Isabelle Massat, et al.
International Clinical Psychopharmacology|May 11, 2010
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorderMagali Noro, Irina Antonijevic, Carlos Forray, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 20, 2012
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorderPeter Höfer, Alexandra Schosser, Raffaella Calati, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 9, 2010
Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypesNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
International Clinical Psychopharmacology|December 29, 2010
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorderNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
Journal of Affective Disorders|July 21, 2010
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depressionAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2003
Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European studyPierre Oswald, Daniel Souery, Isabelle Massat, et al.
Psychiatry Research|December 21, 2010
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depressionAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Neuroscience Letters|May 24, 2011
COMT and age at onset in mood disorders: a replication and extension studyIsabelle Massat, Neslihan Aygun Kocabas, Concetta Crisafulli, et al.
Pageof 3